Role of gp41 glycosylation sites in the biological activity of human immunodeficiency virus type 1 envelope glycoprotein

Virology

Volumn 242, Issue 2, 1998, Pages 338-345

  Perrin, Claire ^a   Fenouillet, Emmanuel ^b   Jones, Ian M ^a  

^a NATURAL ENVIRONMENT RESEARCH COUNCIL   (United Kingdom)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 41; VIRUS GLYCOPROTEIN;

ARTICLE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; T LYMPHOCYTE SUBPOPULATION; VIRUS CELL INTERACTION; VIRUS ENVELOPE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES; VACCINIA;

EID: 0032520597     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.9016     Document Type: Article

References (29)

1. Alexander W. A., Moss B., Fuerst T. R. Regulated expression of foreign genes in vaccinia virus under the control of bacteriophage T7 RNA polymerase and theEscherichia coli. J. Virol. 66:1992;2934-2942.
2. Alkhatib G., Broder C. C., Berger E. A. Cell type-specific fusion cofactors determine human immunodeficiency virus type 1 tropism for T-cell lines versus primary macrophages. J. Virol. 70:1996;5487-5494.
3. Cao J., Bergeron L., Helseth E., Thali M., Repke H., Sodroski J. Effects of amino acid changes in the extracellular domain of the human immunodeficiency virus type 1 gp41 envelope glycoprotein. J. Virol. 67:1993;2747-2755.
4. Chakrabarti L., Guyader M., Alizon M., Daniel M. D., Desrosiers R. C., Tiollais P., Sonigo P. Sequence of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses. Nature. 328:1987;543-547.
5. Chan D. C., Fass D., Berger J. M., Kim P. S. Core structure of gp41 from the HIV envelope glycoprotein. Cell. 89:1997;263-273.
6. Dash B., McIntosh A., Barrett W., Daniels R. Deletion of a single N-linked glycosylation site from the transmembrane envelope protein of human immunodeficiency virus type 1 stops cleavage and transport of gp160 preventing env-mediated fusion. J. Gen. Virol. 75:1994;1389-1397.
7. Dedera D. A., Gu R., Ratner L. Role of asparagine linked glycosylation in human immunodeficiency virus type 1 transmembrane envelope function. Virology. 187:1992;377-382.
8. Dirckx L., Lindemann D., Ette R., Manzoni C., Moritz D., Mous J. Mutation of conserved N-glycosylation sites around the CD4-binding site of human immunodeficiency virus type 1 GP120 affects viral infectivity. Virus Res. 18:1990;9-20.
9. Fenouillet E., Gluckman J.-C., Jones I. M. Functions of HIV envelope glycans. Trends Biol. Sci. 19:1994;65-70.
10. Fenouillet E., Jones I. M., Powell B., Schmitt D., Kieny M. P., Gluckman J. C. Functional role of the glycan cluster of the human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) ectodomain. J. Virol. 67:1993;150-160.
11. Fuerst T. R., Niles E. G., Studier F. W., Moss B. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. USA. 83:1986;8122-8126.
12. Gallaher W. R., Ball J. M., Garry R. F., Griffin M. C., Montelaro R. C. A general model for the transmembrane proteins of HIV and other retroviruses. AIDS Res. Hum. Retro. 5:1989;431-440.
13. Geyer H., Hoischbach C., Hunsmann G., Schneider J. Carbohydrates of human immunodeficiency virus. J. Biol. Chem. 263:1988;11760-11767.
14. Gruters R. A., Neefjes J. J., Tersmette M., De Goede R. E. V., Huisman G., Miedema F., Ploegh H. L. Interference with HIV-induced syncytium formation and viral infectivity by inhibitors of trimming glucosidase. Nature. 330:1987;74-77.
15. Hallenberger S., Bosch V., Angliker H., Shaw E., Klenk H.-D., Garten W. Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160. Nature. 360:1992;358-361.
16. Hemming A., Gram G. J., Bolmstedt A., Losman B., Hansen J. E., Ricksten A., Olofsson S. Conserved N-linked oligosaccharides of the C-terminal portion of human immunodeficiency virus type 1 gp120 and viral susceptibility to neutralizing antibodies. Arch. Virol. 141:1996;2139-2151.
17. Kowalski M., Potz J., Basiripour L., Dorfman T., Goh W. C., Terwilliger E. F., Dayton A., Rosen C., Haseltine W., Sodroski J. Functional domains of the envelope glycoprotein of human immunodeficiency virus type 1. Science. 237:1987;1351-1355.
18. Lee W. R., Yu X. F., Syu W. J., Essex M., Lee T. H. Mutational analysis of conserved N-linked glycosylation sites of human immunodeficiency virus type 1 gp41. J. Virol. 66:1992;1799-1803.
19. Lu M., Blacklow S. C., Kim P. S. A trimeric structural domain of the HIV-1 transmembrane glycoprotein. Nature Struct. Biol. 2:1995;1075-1082.
20. Maddon P. J., Dalgleish A. G., McDougal J. S., Clapham P. R., Weiss R. A., Axel R. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell. 47:1986;333-348.
21. Moore J. P., Sweet R. W. The HIV gp120-CD4 interaction: A target for pharmacological or immunological intervention. Perspect. Drug Discov. Design. 1:1993;235-250.
22. Nussbaum O., Broder C. C., Berger E. A. Fusogenic mechanisms of enveloped-virus glycoproteins analyzed by a novel recombinant vaccinia virus-based assay quantitating cell fusion-dependent reporter gene activation. J. Virol. 68:1994;5411-5422.
23. Otteken A., Earl P. L., Moss B. Folding, assembly, and intracellular trafficking of the human immunodeficiency virus type 1 envelope glycoprotein analyzed with monoclonal antibodies recognizing maturational intermediates. J. Virol. 70:1996;3407-3415.
24. Ratner L. Glucosidase inhibitors for treatment of HIV-1 infection. AIDS. Res. Hum. Retroviruses. 8:1992;165-173.
25. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA. 74:1977;5463-5467.
26. Stein B. S., Engleman E. G. Intracellular processing of the gp160 HIV-1 envelope precursor. Endoproteolytic cleavage occurs in a cis or medial compartment of the Golgi complex. J. Biol. Chem. 265:1990;2640-2649.
27. Weisz O. A., Machamer C. E. Use of recombinant vaccinia virus vectors for cell biology. Methods Cell Biol. 43:1994;137-159.
28. Willey R. L., Bonifacino J. S., Potts B. J., Martin M. A., Klausner R. O. Biosynthesis, cleavage and degradation of the human of the human immunodeficiency virus type-1 envelope glycoprotein gp160. Proc. Natl. Acad. Sci. USA. 86:1988;9580-9584.
29. Willey R. L., Rutledge R. A., Dias S., Folks T., Theodore T., Buckler C. E., Martin M. A. Identification of conserved and divergent domains within the envelope gene of the acquired immunodeficiency syndrome retrovirus. Proc. Natl. Acad. Sci. USA. 83:1986;5038-5042.